Clinical efficacy of 1% Alendronate gel as a local drug delivery system in the treatment of chronic periodontitis: A randomized, controlled clinical trial

Journal of Periodontology

Volumn 83, Issue 1, 2012, Pages 11-18

  Sharma, Anuj ^a   Pradeep, A R ^a  

^a Government Dental College and Research Institute   (India)

Author keywords

Alendronate; Bone regeneration; Chronic periodontitis; Regeneration

Indexed keywords

ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ADULT; ALVEOLAR BONE LOSS; ARTICLE; BONE REGENERATION; CHEMISTRY; CHRONIC PERIODONTITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; GEL; GINGIVITIS; HUMAN; MALE; MIDDLE AGED; PERIODONTAL POCKET; PERIODONTICS; PREVENTIVE DENTISTRY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALENDRONATE; ALVEOLAR BONE LOSS; BONE DENSITY CONSERVATION AGENTS; BONE REGENERATION; CHRONIC PERIODONTITIS; DENTAL SCALING; DRUG DELIVERY SYSTEMS; FEMALE; GELS; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTAL POCKET;

EID: 84863393245     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2011.110091     Document Type: Article

References (38)

1. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol 2008;79(Suppl. 8):1585-1591.
2. Williams RC. Periodontal disease. N Engl J Med 1990; 322:373-382. (Pubitemid 20042743)
3. Baylink DJ, Finkelman RD, Mohan S. Growth factors to stimulate bone formation. J Bone Miner Res 1993; 8(Suppl. 2):S565-S572. (Pubitemid 24015250)
4. Fleisch H. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 1991;42:919-944. (Pubitemid 21920790)
5. Goziotis A, Sukhu B, Torontali M, Dowhaniuk M, Tenenbaum HC. Effects of bisphosphonates APD and HEBP on bone metabolism in vitro. Bone 1995; 16(Suppl. 4):317S-327S.
6. Tenenbaum HC, Torontali M, Sukhu B. Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro. Bone 1992;13:249-255.
7. Giuliani N, Pedrazzoni M, Negri G, Passeri G, Impicciatore M, Girasole G. Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 1998;22:455-461.
8. VittéC, Fleisch H, Guenther HL. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology 1996;137: 2324-2333.
9. Jeffcoat MK, Cizza G, Shih WJ, Genco R, Lombardi A. Efficacy of bisphosphonates for the control of alveolar bone loss in periodontitis. J Int Acad Periodontol 2007; 9:70-76.
10. El-Shinnawi UM, El-Tantawy SI. The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial). J Int Acad Periodontol 2003;5:5-10.
11. Lane N, Armitage GC, Loomer P, et al. Bisphosphonate therapy improves the outcome of conventional periodontal treatment: Results of a 12-month, randomized, placebo-controlled study. J Periodontol 2005;76:1113-1122. (Pubitemid 41065401)
12. Menezes AM, Rocha FA, Chaves HV, Carvalho CB, Ribeiro RA, Brito GA. Effect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats. J Periodontol 2005;76:1901-1909. (Pubitemid 41748979)
13. Reddy MS, Weatherford TW 3rd, Smith CA, West BD, Jeffcoat MK, Jacks TM. Alendronate treatment of naturally-occurring periodontitis in beagle dogs. J Periodontol 1995;66:211-217.
14. Weinreb M, Quartuccio H, Seedor JG, et al. Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys. J Periodontal Res 1994;29:35-40.
15. Yaffe A, Fine N, Alt I, Binderman I. Effect of bisphosphonate on alveolar bone resorption following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 1995;66:999-1003.
16. Yaffe A, Fine N, Binderman I. Regional accelerated phenomenon in the mandible following mucoperiosteal flap surgery. J Periodontol 1994;65:79-83.
17. Reddy GT, Kumar TM, Veena KM. Formulation and evaluation of alendronate sodium gel for the treatment of bone resorptive lesions in periodontitis. Drug Deliv 2005;12:217-222. (Pubitemid 40981284)
18. Binderman I, Adut M, Yaffe A. Effectiveness of local delivery of alendronate in reducing alveolar bone loss following periodontal surgery in rats. J Periodontol 2000;71:1236-1240. (Pubitemid 30655955)
19. Yaffe A, Iztkovich M, Earon Y, Alt I, Lilov R, Binderman I. Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats. J Periodontol 1997;68: 884-889. (Pubitemid 27411022)
20. Wang HL, Weber D, McCauley LK. Effect of long-term oral bisphosphonates on implant wound healing: Literature review and a case report. J Periodontol 2007;78:584-594.
21. Soileau KM. Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy. J Periodontol 2006; 77:738-743. (Pubitemid 44725063)
22. Brägger U, Pasquali L, Kornman KS. Remodelling of interdental alveolar bone after periodontal flap procedures assessed by means of computer-assisted densitometric image analysis (CADIA). J Clin Periodontol 1988;15:558-564.
23. Wood DL, Hoag PM, Donnenfeld OW, Rosenfeld LD. Alveolar crest reduction following full and partial thickness flaps. J Periodontol 1972;43:141-144.
24. Mombelli A, van Oosten MA, Schurch E Jr., Land NP. The microbiota associated with successful or failing implants. Oral Microbiol Immunol 1987;2:145-151.
25. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
26. Pradeep AR, Sharma A. Autologous platelet rich fibrin in the treatment of mandibular Degree II furcation defects: A randomized clinical trial. J Periodontol 2011;82:1396-1403.
27. Lin JH, Chen IW, deLuna FA. On the absorption of alendronate in rats. J Pharm Sci 1994;83:1741-1746.
28. Fleisch H. Bisphosphonates: Mechanisms of action. Endocr Rev 1998;19:80-100. (Pubitemid 29122075)
29. Srisubut S, Teerakapong A, Vattraphodes T, Taweechaisupapong S. Effect of local delivery of alendronate on bone formation in bioactive glass grafting in rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:e11-e16.
30. Luckman SP, Coxon FP, Ebetino FH, Russell RGG, Rogers MJ. Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: Evidence from structureactivity relationships in J774 macrophages. J Bone Miner Res 1998;13:1668-1678. (Pubitemid 28491995)
31. Rocha M, Nava LE, Vázquez de la Torre C, Sánchez- Márin F, Garay-Sevilla ME, Malacara JM. Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: A randomized, placebo-controlled trial. J Periodontol 2001;72:204-209.
32. Brunsvold MA, Chaves ES, Kornman KS, Aufdemorte TB, Wood R. Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol 1992; 63:825-830.
33. The American Academy of Periodontology. The role of controlled drug delivery for periodontitis [position paper; rescinded May 2003]. J Periodontol 2000;71:125-140.
34. Needleman IG, Pandya NV, Smith SR, Foyle DM. The role of antibiotics in the treatment of periodontitis (part 2 -controlled drug delivery). Eur J Prosthodont Restor Dent 1995;3:111-117.
35. Fleisch H, Felix R. Diphosphonates. Calcif Tissue Int 1979;27:91-94.
36. Jones DS, Brown AF, Woolfson AD. Rheological characterization of bioadhesive, antimicrobial, semisolids designed for the treatment of periodontal diseases: Transient and dynamic viscoelastic and continuous shear analysis. J Pharm Sci 2001;90:1978-1990. (Pubitemid 33144444)
37. Perioli L, Ambrogi V, Rubini D, et al. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J Control Release 2004;95:521-533. (Pubitemid 38340502)
38. Jones DS, Woolfson AD, Djokic J, Coulter WA. Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm Res 1996;13:1734-1738. (Pubitemid 26426902)